About
Pro-med(Beijing)Technology Co., Ltd is a national high-tech enterprise which is focused on IVD and established in 2013 Beijing, Pro-med has constructed a complete system of R&D, producing and sales of IVD agents and instruments, is capable to provide series of qualitative assays(colloidal gold), qualitative assays(Fluorescence immunochromatography) and COVID-19 related assays. Pro-med products are reputable and has been used and tested in more than 10,000 medical services all over the world. 40 core patents and 90 product certificates . Now the company owns two business center, the production and R&D center locates in Beijing with 18,000 m2 production area and the Technology & Sales center in Suzhou, Jiangsu Province. 700 employees and 4200 m2 GMP work area, leads daily production capacity exceeds 3 million. Now Pro-med has won its reputation in POCT filed, also the Fluorescence quantitative testing platform has taken the lead in China for accurate results and simplified operation, the scope of application covers maternal and children health, inflammation and infection, gastric screening(stomach health), cardio-cerebral vascular health and etc. To help prevent COVID-19 spreading, Pro-med prepared kinds of detection solutions, including the COVID-19 Antigen with both Nasal swab and Saliva test, COVID-19 IgG/IgM Antibody and COVID-19 neutralized antibody. By the advantage of self-produced core IVD raw materials and strict quality control, Pro-med has obtained ISO, CE certificates and China whitelists, our self-test has been approved by Germany BfArm, Italian Salute, Austrian BASG, also the approval list of France, Netherlands, Denmark, Thailand and other countries are in application. With mature producing system, Pro-med determined to become a global leading grouping-enterprise in IVD industry.
Technologies
Keywords
Company Information
-
Employees 4
-
Founded 2013
Location
Beijing, Beijing, China